Evalution the Effects of Raloxifene and Risedronate on Serum Biochemical Markers
Objective: Osteoporosis a progressive bone disease that is characterized by a decrease in bone mass which can lead to an increased risk of fracture. Osteoporosis is still a global public health problem. In recent years, many new osteoporosis drugs have become available but none of them is totally...
Main Authors: | Abdurrahman Yeter, Vural Kavuncu, Fatma Deniz Evcik, Ümit Seçil Demirdal, Volkan Subaşı, Tuncay Çakır |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2014-12-01
|
Series: | Türk Osteoporoz Dergisi |
Subjects: | |
Online Access: | http://www.turkosteoporozdergisi.org/article_7596/Evalution-The-Effects-Of-Raloxifene-And-Risedronate-On-Serum-Biochemical-Markers |
Similar Items
-
The Effects of Once-Weekly Alendronate 70 mg, Risedronate 35 mg and Raloxifene 60 mg Daily in the Treatment of Postmenopausal Osteoporosis in Turkish Population
by: Mesut Öktem, et al.
Published: (2007-04-01) -
Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01) -
The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01) -
The Effects of Risedronate Therapy Combined With Vitamin D and Calcium on Biochemical Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporosis
by: Hüsniye Koç, et al.
Published: (2004-12-01) -
Role of raloxifene in the management of postmenopausal osteoporosis of rheumatoid arthritis patients
by: Salari M., et al.
Published: (2023-09-01)